Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Ontologizer 3: a cross-platform desktop application for frequentist and Bayesian GO enrichment analysis

Created on 08 Jun 2026

Authors

Ramlow, L., Scholtes, J., Danis, D., Robinson, P. N.

Abstract

We present Ontologizer 3, an easy-to-use cross-platform desktop application for Gene Ontology (GO) overrepresentation analysis. Ontologizer 3 offers two complementary methods. The first is a frequentist approach that evaluates GO terms individually using a one-sided Fisher's exact test, yielding term-level significance values. The second is a Bayesian approach that jointly evaluates terms using model-based gene set analysis (MGSA), yielding term-level posterior probabilities. Due to substantial overlap among annotated gene sets resulting from the GO's hierarchical structure, the two methods produce different results. The frequentist approach tends to report a lengthy list of terms with strong annotation overlap, whereas, MGSA yields a parsimonious set of terms that explain the observed gene activity. Using simulated data with a known ground truth, we demonstrate that both methods reliably identify the causal term, but MGSA achieves substantially higher precision. Ontologizer 3 is implemented as a Tauri application with a Rust backend and an Angular frontend, presenting enriched terms in tabular and graphical form. The software is freely available under the MIT licence at https://github.com/P2GX/ontologizer-gui. Installation packages for Macintosh, Windows and Debian-based Linux are available on the GitHub Releases page.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 08 Jun 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement